[Ivermectin. A new drug against onchocerciasis].
O Otterlei
Abstract
O Otterlei
Abstract
Ivermectin is a new drug for treatment of onchocerciasis. Experimental and clinical studies have shown that ivermectin is effective in the treatment of onchocerciasis when given as a single dose of 150 microgram/kilo bodyweight once a year. Ivermectin is registered as Mectizan and is at present supplied free of charge by Merck Sharp & Dohme for treatment programs in 11 developing countries.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Ivermectin is a new drug for treatment of onchocerciasis. Experimental and clinical studies have shown that ivermectin is effective in the treatment of onchocerciasis when given as a single dose of 150 microgram/kilo bodyweight once a year. Ivermectin is registered as Mectizan and is at present supplied free of charge by Merck Sharp & Dohme for treatment programs in 11 developing countries.
Key concepts: Ivermectin, Onchocerciasis, Onchocerca volvulus, Antiparasitic agent, Drug, Medicine, Pharmacology, Biology